TGFB1 and neoplasm: Consistent with these associations between TGFB1 variations and clinicopathological characteristics, the progression risk during ADT was associated with TGFB1 genotypes, suggesting that TGFB1 genotypes were associated with PFS through unfavorable tumor characteristics.